Shigeo Ichihashi/LinkedIn
Oct 18, 2025, 05:13
The CLARIFY IMA Study From Shigeo Ichihashi and Colleagues was Recently Published!
Vascular News shared Shigeo Ichihashi’s and colleagues latest study on LinkedIn:
“Results from a multicentre randomised controlled trial indicate that pre-emptive inferior mesenteric artery (IMA) embolisation during endovascular aneurysm repair (EVAR) does not significantly reduce aneurysm sac volume or rates of type II endoleak.
The CLARIFY IMA study from Shigeo Ichihashi (Nara Medical University, Nara, Japan) and colleagues was recently published in the European Journal of Vascular and Endovascular Surgery (EJVES) and presented at the 39th European Society for Vascular Surgery annual meeting (23–26 September, Istanbul, Türkiye).”
Read more here.
Stay updated about IMA latest news with Hemostasis Today.
-
Feb 26, 2026, 15:58Daniel Victor Ortigoza։ Lipoprotein(a) Levels Predict Long-Term Cardiovascular Risk in Women
-
Feb 26, 2026, 15:51Augustina Isioma Ikusemoro: The Real Miracle in Trauma Care Happens Behind the Scenes
-
Feb 26, 2026, 15:42Jim Hoffman։ Targeting NETosis to Improve Perfusion and Reduce Thrombosis in AMI
-
Feb 26, 2026, 15:40Elvira Grandone: ISTH Launches An International Survey to Capture Real-World Practice of Pregnancy Anemia
-
Feb 26, 2026, 15:39Ashok Yadav: Placental Glycogen as a Vital Energy Reserve for Fetal and Placental Health
-
Feb 26, 2026, 15:37Nayab Ahmed: Main Reasons for Washing Platelet-Rich Plasma
-
Feb 26, 2026, 15:36Robert Negrin Shares His Outlook for the Year Ahead as ASH President
-
Feb 26, 2026, 15:24Nancy Shapiro: Excited to See This Publication on Current Landscape of Anticoagulation Stewardship Released
-
Feb 26, 2026, 15:15Ahmed Nasreldein: Stay Current on Key Updates in Ischemic and Hemorrhagic Stroke